MLAB — Mesa Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $543.40m
- $748.14m
- $219.08m
- 71
- 34
- 47
- 49
Annual cashflow statement for Mesa Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.48 | 1.78 | 3.27 | 1.87 | 0.93 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.75 | 17.3 | 14.4 | 19.3 | 13.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.89 | -3.14 | 5.25 | -7.19 | -17.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 30.6 | 27 | 37.1 | 39.2 | 28 |
| Capital Expenditures | -1.26 | -1.5 | -1.99 | -4.43 | -4.54 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.62 | -184 | 0 | -301 | -4.95 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -3.88 | -186 | -1.99 | -305 | -9.49 |
| Financing Cash Flow Items | -0.68 | -5.44 | -0.968 | -0.237 | -0.919 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -21.7 | 231 | 146 | 52.6 | -33.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.72 | 71.2 | 182 | -215 | -16.4 |